A Success Story of Complicated Antipartum Hemorrage and Placenta Previa in ICU Setting |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.11, No. 3)Publication Date: 2020-12-15
Authors : Ashraf S; Sebtain A; Iqbal Z Laiq N; Jawad; Abid;
Page : 262-263
Keywords : Antepartum; Hemorrhage; Fertilization; Antibiotics; Ventilator;
Abstract
Pharmacogenomic testing identifies genetic variants that help clinicians determine an individual's expected response to medications. Results from pharmacogenomic testing may provide valuable information on the expected response to a drug while on the other hand, results may also help explain adverse drug events (ADEs), identify patients who may require closer monitoring to avoid ADEs, and avoid specific drugs that are expected to cause ADEs in certain individuals. Many ADEs are believed to have a genetic component. Drugs administered at normal doses may interact with a gene that has a genetic variant affecting the drug's response. Pharmacogenomic testing can identify genetic variants that encode specific CYP enzymes (e.g., CYP2C9, CYP2C19, CYP2D6, and CYP3As). It is estimated that drug-gene and drug-drug-gene interactions contribute to about one-third of potential major or substantial drug interactions that occur in patients. Pharmacogenomic testing can predict about 20 to 30 percent of ADEs and significantly reduce ADE associated deaths.
Other Latest Articles
- Detection of Diabetic Retinopathy in Retinal Image Early Identification using Deep CNN
- AN ANTI–CRISIS PLAN AS AN EFFECTIVE MECHANISM FOR THE FUNCTIONING OF AN ENTERPRISE IN A CRISIS
- Attribute Based Ecdsa Searchable Encryption in Cloud Computing ECDSA Elliptic Curve Digital Signature Algorithm
- Cryptocurrency Market Movement and Tendency Forecasting using Twitter Emotion and Information Quantity
- Studies on Strength and Durability of Concrete Made with Manufactured Sand
Last modified: 2023-07-20 21:52:00